Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Radical prostatectomy for high-risk prostate cancer | Opinion: YES.

Reis LO, Montenegro R, Trinh QD.

Int Braz J Urol. 2019 May-Jun;45(3):424-427. doi: 10.1590/S1677-5538.IBJU.2019.03.02. No abstract available.

2.

Radical prostatectomy for high-risk prostate cancer | Opinion: NO.

Ghodoussipour S, Cacciamani GE, Abreu ALC.

Int Braz J Urol. 2019 May-Jun;45(3):428-434. doi: 10.1590/S1677-5538.IBJU.2019.03.03. No abstract available.

3.

Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: Yes.

Costa WH, GuimarĂ£es GC.

Int Braz J Urol. 2016 Sep-Oct;42(5):876-879. doi: 10.1590/S1677-5538.IBJU.2016.05.04. No abstract available.

4.

Difference of opinion - Radical prostatectomy in metastatic prostate cancer: is there enough evidence? | Opinion: No.

Ristau BT, Smaldone MC.

Int Braz J Urol. 2016 Sep-Oct;42(5):880-882. doi: 10.1590/S1677-5538.IBJU.2016.05.05. No abstract available.

5.

Identification of curable high-risk prostate cancer using radical prostatectomy alone: who are the good candidates for undergoing radical prostatectomy among patients with high-risk prostate cancer?

Nagao K, Matsuyama H, Matsumoto H, Nasu T, Yamamoto M, Kamiryo Y, Baba Y, Suga A, Tei Y, Yoshihiro S, Aoki A, Shimabukuro T, Joko K, Sakano S, Takai K, Yamaguchi S, Akao J, Kitahara S; Yamaguchi Uro-Oncology Group.

Int J Clin Oncol. 2018 Aug;23(4):757-764. doi: 10.1007/s10147-018-1272-9. Epub 2018 Mar 27.

6.

Is radical prostatectomy appropriate for very-high-risk prostate cancer patients? Yes.

Maroni PD.

Oncology (Williston Park). 2015 May;29(5):348, 388. No abstract available.

7.

Focal therapy will be the next step on prostate cancer management? | Opinion: Yes.

Zequi SC.

Int Braz J Urol. 2017 Nov-Dec;43(6):1013-1016. doi: 10.1590/S1677-5538.IBJU.2017.06.02. No abstract available.

8.

External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.

Moschini M, Zaffuto E, Karakiewicz PI, Andrea DD, Foerster B, Abufaraj M, Soria F, Mattei A, Montorsi F, Briganti A, Shariat SF.

Eur Urol. 2019 Feb;75(2):319-328. doi: 10.1016/j.eururo.2018.09.034. Epub 2018 Oct 4.

PMID:
30293908
9.

Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.

Nieder AM, Porter MP, Soloway MS.

J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.

PMID:
18801517
10.

Is radical prostatectomy an option in high-risk prostate cancer patients?

Karazanashvili G, Muller S.

Georgian Med News. 2007 Feb;(143):21-6. Review.

PMID:
17404433
11.

Early radiotherapy after radical prostatectomy improves cancer-specific survival only in patients with highly aggressive prostate cancer: validation of recently released criteria.

Gandaglia G, Karakiewicz PI, Briganti A, Trudeau V, Trinh QD, Kim SP, Montorsi F, Nguyen PL, Abdollah F, Sun M.

Int J Urol. 2015 Jan;22(1):89-95. doi: 10.1111/iju.12605. Epub 2014 Aug 21.

12.

Radical Prostatectomy for High-risk Localized or Node-Positive Prostate Cancer: Removing the Primary.

Matulay JT, DeCastro GJ.

Curr Urol Rep. 2017 Jul;18(7):53. doi: 10.1007/s11934-017-0703-x. Review.

PMID:
28589400
13.

SABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.

Eccles BK, Cross W, Rosario DJ, Doble A, Parker C, Logue J, Little L, Stanton L, Bottomley D.

BJU Int. 2013 Aug;112(3):330-7. doi: 10.1111/bju.12127.

14.

Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.

Abdollah F, Sun M, Schmitges J, Thuret R, Bianchi M, Shariat SF, Briganti A, Jeldres C, Perrotte P, Montorsi F, Karakiewicz PI.

J Urol. 2012 Jul;188(1):73-83. doi: 10.1016/j.juro.2012.03.005. Epub 2012 May 12.

PMID:
22578732
15.

[Indications for and results of radical prostatectomy].

Graefen M, Hammerer PG, Haese A, Huland H.

Urologe A. 2003 Sep;42(9):1203-11. Review. German.

PMID:
14504753
16.

Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup.

Moschini M, Sharma V, Zattoni F, Boorjian SA, Frank I, Gettman MT, Thompson RH, Tollefson MK, Kwon ED, Karnes RJ.

J Urol. 2016 Jun;195(6):1773-8. doi: 10.1016/j.juro.2015.12.074. Epub 2015 Dec 23.

PMID:
26723866
17.

Difference of opinion - Active surveillance in intermediate risk prostate cancer: is it safe? Opinion: Yes.

van der Poel HG, van den Bergh RC.

Int Braz J Urol. 2016 May-Jun;42(3):413-7. doi: 10.1590/S1677-5538.IBJU.2016.03.03. No abstract available.

18.

High-risk localized prostate cancer: role of radical prostatectomy.

Grubb RL, Kibel AS.

Curr Opin Urol. 2010 May;20(3):204-10. doi: 10.1097/MOU.0b013e3283384101. Review.

PMID:
20216315
19.

Radical prostatectomy after radiotherapy for prostatic cancer.

Carson CC 3rd, Zincke H, Utz DC, Cupps RE, Farrow GM.

J Urol. 1980 Aug;124(2):237-9.

PMID:
7401237
20.

Nomogram Predicting Prostate Cancer-specific Mortality for Men with Biochemical Recurrence After Radical Prostatectomy.

Brockman JA, Alanee S, Vickers AJ, Scardino PT, Wood DP, Kibel AS, Lin DW, Bianco FJ Jr, Rabah DM, Klein EA, Ciezki JP, Gao T, Kattan MW, Stephenson AJ.

Eur Urol. 2015 Jun;67(6):1160-1167. doi: 10.1016/j.eururo.2014.09.019. Epub 2014 Oct 6.

Supplemental Content

Support Center